4D Molecular Therapeutics, Inc. (FDMT) News
Track canonical SquawkNews coverage tagged to FDMT, 4D Molecular Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
FDMT/4DMT announces new employment inducement grants
FDMT, also known as 4DMT, announces new employment inducement grants, with no further details provided in the feed.
EQUITY | Aug 14, 2026, 08:05 PM UTC
L
4DMT (FDMT) reports Q2 2026 financial results and operational highlights
FDMT—4DMT reports its second quarter 2026 financial results along with operational highlights and expected upcoming milestones.
EARNINGS | Aug 13, 2026, 08:05 PM UTC
H
FDMT Initiated Buy at B.Riley
B.Riley initiates FDMT buy
EQUITY | Jul 31, 2026, 11:55 AM UTC
H
Cantor Initiates DUOT Overweight
Banks initiate coverage on several stocks
EQUITY | Jul 31, 2026, 11:38 AM UTC
H
FDMT Rated Buy
FDMT rated new buy
EQUITY | Jul 31, 2026, 11:23 AM UTC
L
FDMT - per Saturday PR: 4D Molecular Therapeutics' 4D-150 Achieves 78% Overall Treatment Burden Reduction At 2 Years, With 87% Reduction In
FDMT - per Saturday PR: 4D Molecular Therapeutics' 4D-150 Achieves 78% Overall Treatment Burden Reduction At 2 Years, With 87% Reduction In Recently Diagnosed Wet Age-Related Macular Degeneration Subgroup
EQUITY | Jul 20, 2026, 01:15 PM UTC